Marchex (MCHX) COO converts 62,500 RSUs into Class B shares

Rhea-AI Filing Summary

Marchex Inc. Chief Operating Officer & CLO Francis J. Feeney exercised 62,500 restricted stock units into the same number of Class B Common Stock shares. The units, granted effective March 20, 2025, vested in full on the first anniversary and converted at a zero exercise price as part of his equity compensation.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Feeney Francis J

(Last) (First) (Middle)

1200 5TH AVE

SUITE 1300

(Street)

SEATTLE WASHINGTON 98101

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
MARCHEX INC [ MCHX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Operating Officer & CLO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/20/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class B Common Stock	03/20/2026		M		62,500	A	(1)	299,928	D
Class B Common Stock								40,000(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	03/20/2026		M			62,500	(1)	(1)	Class B Common Stock	62,500	$0	0	D

Explanation of Responses:

1. Restricted stock units award effective March 20, 2025 (the "Grant Date"). Each restricted stock unit represents the right to receive one share of the Corporation's Class B Common Stock upon vesting, which occurs in full on the first anniversary of the Grant Date.

2. Restricted stock award effective January 3, 2023 (the "Grant Date"), with 25% of such shares vesting on the first, second, third, and fourth annual anniversary of the Grant Date, subject to remaining a continuous and full-time active employee.

	/s/ Francis J Feeney	03/20/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Marchex (MCHX) report for Francis J. Feeney?

Marchex reported that COO & CLO Francis J. Feeney exercised 62,500 restricted stock units into 62,500 Class B Common Stock shares. This was a derivative exercise at a zero exercise price, reflecting settlement of previously granted equity compensation.

When did Francis J. Feeney’s Marchex restricted stock units vest?

The 62,500 restricted stock units vested on the first anniversary of their March 20, 2025 grant date. According to the terms, all units vested in full after one year, triggering their conversion into Class B Common Stock on March 20, 2026.

Was Francis J. Feeney’s Marchex Form 4 transaction an open-market purchase or sale?

The Form 4 shows a derivative exercise, not an open-market purchase or sale. Code M indicates an exercise or conversion of restricted stock units into Class B Common Stock at a stated price of zero dollars per share.

How many Marchex Class B shares did Francis J. Feeney receive from the RSU exercise?

He received 62,500 shares of Marchex Class B Common Stock. Each restricted stock unit represented the right to receive one share upon vesting, so all 62,500 vested units converted into an equal number of Class B shares.

What role does Francis J. Feeney hold at Marchex (MCHX) in this Form 4?

Francis J. Feeney is identified as Chief Operating Officer & Chief Legal Officer of Marchex Inc. The reported transaction reflects equity compensation tied to his executive role, rather than discretionary market trading in Marchex shares.